Oxford’s Vaccine Results Still Puzzle, AZ Expects Not To File With FDA
But UK, EU and India Decisions Anticipated
Partners hope non-US regulators will authorize early and then await later readouts to clarify vaccine's profile, but FDA is expected to hold out for US trial data.
